Wednesday, October 12, 2016

Cobamamide




In some countries, this medicine may only be approved for veterinary use.

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

B03BA04

CAS registry number (Chemical Abstracts Service)

0013870-90-1

Chemical Formula

C72-H100-Co-N18-O17-P

Molecular Weight

1579

Therapeutic Category

Vitamin B₁₂

Chemical Name

5'-Deoxyadenosylcobolamine

Foreign Names

  • Cobamamidum (Latin)
  • Cobamamid (German)
  • Cobamamide (French)
  • Cobamamida (Spanish)

Generic Names

  • Cobamamide (OS: JAN)
  • Dibencozide (OS: DCF)
  • Coenzyme B₁₂ (IS)
  • Dimebenzcozamide (IS)
  • LM 176 (IS)

Brand Names

  • Aktibol
    Mustafa Nevzat, Turkey


  • Bidicozan
    Bidiphar, Vietnam


  • Biotrefon-L
    Italmex, Mexico


  • Calomide
    Astellas, Japan; Astellas, Taiwan


  • Cobaforte
    EG, Italy


  • Cobaltamin-S
    Wakamoto, Japan


  • Cobamyde
    Kyowa Hakko Kirin, Japan


  • Cobaxid
    Tecnifar, Portugal


  • Cobazim
    Interbat, Indonesia


  • Co-Carnetina B12
    Sigma Tau, Italy


  • Coenzile (veterinary use)
    Ati, Italy; Fatro, Italy


  • Covitasa B12 (Cobamamide and Cyproheptadine)
    Seid, Spain


  • Dobenzic
    Domesco, Vietnam


  • Enzicoba
    Farmasa, Brazil


  • Heraclene
    Natrapharm, Philippines


  • Hycobal
    Eisai, Japan


  • Indusil
    Recordati, Italy


  • Maxibol
    Sanofi-Aventis, Mexico; Sanofi-Aventis, Venezuela


  • Sanovit
    Altana, Mexico


  • Sim 12
    Cipa, Peru


  • Tonico Juventus (Cobamamide and Cyproheptadine)
    Juventus, Spain


  • Vitadrop (Cobamamide and Hyaluronic acdi)
    Kalbe, Indonesia


  • Xobalin
    Sanofi-Aventis, Ecuador


  • Zimadoce
    Rubio, Spain

International Drug Name Search

Glossary

DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment